We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Intra-articular Glucocorticoid Treatment of the Elbow

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00972530
First Posted: September 7, 2009
Last Update Posted: November 11, 2009
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
Meda AB
Information provided by:
Department of Research and Development, County Council of Gavleborg and Uppsala University
  Purpose

BACKGROUND: Intra-articular glucocorticoid injections are frequently used to relieve symptoms of arthritis. Postinjection rest has been shown to improve the outcome of knee joint injections, but not for wrist injections. Consequently, different joints respond differently on postinjection regimens.

OBJECTIVES: To investigate whether better treatment results might be achieved of post-injection rest following intra-articular glucocorticoid treatment for elbow synovitis.

METHODS: 90 patients with rheumatoid arthritis (RA) and elbow synovitis were treated with 20 mg intra-articular triamcinolone hexacetonide and randomised to either a 48 hour immobilisation in a triangular sling (n=46) or normal activity without restrictions (n=44). Primary endpoint was relapse of synovitis. In addition, pain, function according to a self assessment questionnaire (PREE) and range of movement were followed for six months.


Condition Intervention
Rheumatoid Arthritis Behavioral: immobilisation in a triangular sling

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: The Importance of Immobilisation After Intra-articular Glucocorticoid Treatment for Elbow Synovitis - a Randomised and Controlled Study

Resource links provided by NLM:


Further study details as provided by Department of Research and Development, County Council of Gavleborg and Uppsala University:

Primary Outcome Measures:
  • Relapse of Arthritis [ Time Frame: Regular visits at one week, 3 months and 6 months. ]

Enrollment: 90
Study Start Date: January 2006
Study Completion Date: December 2008
Primary Completion Date: December 2008 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
No Intervention: Activity
Normal activity without restrictions
Active Comparator: immobilisation
48 hours postinjection rest
Behavioral: immobilisation in a triangular sling

Intervention group: Immobilisation 48 hours in a triangular sling (mitella)

Control group: normal activity without restrictions

Other Names:
  • Postinjection rest
  • normal joint usage

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Rheumatoid arthritis, and
  • Clinical signs of elbow synovitis

Exclusion Criteria:

  • Patients in function class 4 according to Steinbrocker as well as patients with oral glucocorticoid treatment corresponding to more than 7.5 mg prednisolone or intra-articular treatment in the joint the past three months
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00972530


Sponsors and Collaborators
Department of Research and Development, County Council of Gavleborg and Uppsala University
Meda AB
Investigators
Principal Investigator: Tomas Weitoft, MD PhD Department of Research and Development County Council of Gävleborg/Uppsala University
  More Information

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: MD PhD Tomas Weitoft, Department of Research and Development, County Council of Gavleborg and Uppsala University
ClinicalTrials.gov Identifier: NCT00972530     History of Changes
Other Study ID Numbers: Dnr 2005:362
First Submitted: September 3, 2009
First Posted: September 7, 2009
Results First Submitted: September 10, 2009
Results First Posted: November 11, 2009
Last Update Posted: November 11, 2009
Last Verified: October 2009

Keywords provided by Department of Research and Development, County Council of Gavleborg and Uppsala University:
rheumatoid arthritis
treatment

Additional relevant MeSH terms:
Arthritis
Arthritis, Rheumatoid
Joint Diseases
Musculoskeletal Diseases
Rheumatic Diseases
Connective Tissue Diseases
Autoimmune Diseases
Immune System Diseases
Glucocorticoids
Hormones
Hormones, Hormone Substitutes, and Hormone Antagonists
Physiological Effects of Drugs